Lipocine Inc. 4
4 · Lipocine Inc. · Filed May 18, 2015
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Mattila Jyrki
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-05-15+80,000→ 80,000 totalExercise: $7.66Exp: 2025-05-14→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary date of May 15, 2016, with the remaining 2/3 of the shares vesting monthly on a pro-rata basis over the following two years.